{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:22:43Z","timestamp":1791573763466,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.eplepsyres.2020.106347","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T08:02:53Z","timestamp":1589875373000},"page":"106347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Antiepileptic drugs for acute encephalitic patients presented with seizure"],"prefix":"10.1016","volume":"164","author":[{"given":"Anjiao","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmiao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2020.106347_bib0005","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1586\/ern.11.51","article-title":"Etiologies of epilepsy: a comprehensive review","volume":"11","author":"Bhalla","year":"2011","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.eplepsyres.2020.106347_bib0010","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s13311-016-0433-7","article-title":"Herpes simplex Virus-1 encephalitis in adults: pathophysiology, diagnosis, and management","volume":"13","author":"Bradshaw","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.eplepsyres.2020.106347_bib0015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/imj.12749","article-title":"Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand","volume":"45","author":"Britton","year":"2015","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.eplepsyres.2020.106347_bib0020","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1177\/7010.2006.00223","article-title":"Clinical characteristics and prognostic factors of postencephalitic epilepsy in children","volume":"21","author":"Chen","year":"2006","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2020.106347_bib0025","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-Year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.eplepsyres.2020.106347_bib0030","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1212\/NXI.0000000000000353","article-title":"Antiepileptic drug therapy in patients with autoimmune epilepsy","volume":"4","author":"Feyissa","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.eplepsyres.2020.106347_bib0035","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1111\/j.1440-1819.2004.01244_3.x","article-title":"Etiologic factors and clinical features of symptomatic epilepsy: focus on pediatric cases","volume":"58","author":"Fujiwara","year":"2004","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.eplepsyres.2020.106347_bib0040","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/WNL.0b013e3181f11d65","article-title":"Challenge of the unknown. A systematic review of acute encephalitis in non-outbreak situations","volume":"75","author":"Granerod","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2020.106347_bib0045","article-title":"Clinical epidemiology, risk factors, and outcomes of encephalitis in older adults","author":"Hansen","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.eplepsyres.2020.106347_bib0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0920-1211(96)00086-1","article-title":"Epilepsy after central nervous system infection: clinical characteristics and outcome after epilepsy surgery","volume":"25","author":"Lancman","year":"1996","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2020.106347_bib0055","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejpn.2007.02.011","article-title":"Risk factors for postencephalitic epilepsy in children: a hospital-based study in Taiwan","volume":"11","author":"Lee","year":"2007","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2020.106347_bib0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0887-8994(00)00269-1","article-title":"Predictors and underlying causes of medically intractable localization-related epilepsy in childhood","volume":"24","author":"Ohtsuka","year":"2001","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2020.106347_bib0065","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010247.pub3","article-title":"Antiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitis","author":"Pandey","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.eplepsyres.2020.106347_bib0070","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1111\/epi.13253","article-title":"Postencephalitic epilepsy and drug-resistant epilepsy after infectious and antibody-associated encephalitis in childhood: clinical and etiologic risk factors","volume":"57","author":"Pillai","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106347_bib0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/epi.12879","article-title":"Postencephalitic epilepsy: clinical characteristics and predictors","volume":"56","author":"Singh","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106347_bib0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.medmal.2017.01.005","article-title":"Guidelines on the management of infectious encephalitis in adults","volume":"47","author":"Stahl","year":"2017","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.eplepsyres.2020.106347_bib0085","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2013Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106347_bib0090","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/cid\/cit458","article-title":"Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium","volume":"57","author":"Venkatesan","year":"2013","journal-title":"Clin. Infect. Dis."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121120300358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121120300358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:43:23Z","timestamp":1760276603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121120300358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":18,"alternative-id":["S0920121120300358"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106347","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiepileptic drugs for acute encephalitic patients presented with seizure","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106347"}}